Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group

  • 1Email author,
  • 1,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7 and
  • 8, 9
Cardiovascular Diabetology201716:135

https://doi.org/10.1186/s12933-017-0616-5

  • Received: 6 October 2017
  • Accepted: 6 October 2017
  • Published:

The original article was published in Cardiovascular Diabetology 2017 16:35

Correction to: Cardiovasc Diabetol (2017) 16:35 DOI 10.1186/s12933-017-0508-8

Following publication of the original article [1], author Antonio Ceriello requested that a correction be published in relation to his affiliations. His correct affiliations have been updated in this erratum. This correction is very important for the correct assignment of funds to his Institutions.

Notes

Declarations

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany
(2)
Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd, No. 145, 900591 Constanta, Romania
(3)
Diabetes and Metabolic Disease Unit, IRCCS MultiMedica, Via Milanese 300, 20099 Sesto San Giovanni, MI, Italy
(4)
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia
(5)
3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, U Nemocnice 1, 128 08 Prague 2, Czech Republic
(6)
Department of Endocrinology Diabetology Nutrition, CINFO, CRNH-IdF, Jean VERDIER Hospital, Paris 13 University, Avenue du 14 Juillet, 93140 Bondy, France
(7)
Diabetes and Metabolic Disorders, Dubrava University Hospital, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia
(8)
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigacion Biomèdica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Barcelona, Spain
(9)
Department of Cardiovascular and Metabolic Diseases, IRCCS Multimedica, Sesto San Giovanni, Milan, Italy

Reference

  1. Schnell O, Stand E, Catrinoiu D, Genovese S, Lalic N, Skra J, Valensi P, Rahelic D, Ceriello A. Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group. Cardiovasc Diabetol. 2017;16:35. doi:10.1186/s12933-017-0508-8.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement